Core Viewpoint - Rosen Law Firm is reminding investors who purchased KBR, Inc. securities between May 6, 2025, and June 19, 2025, of the upcoming lead plaintiff deadline for a securities class action lawsuit set for November 18, 2025 [1]. Group 1: Class Action Details - Investors who bought KBR securities during the specified Class Period may be eligible for compensation without any out-of-pocket fees through a contingency fee arrangement [2]. - A class action lawsuit has already been filed, and those wishing to serve as lead plaintiff must act by November 18, 2025 [3]. - The lawsuit alleges that KBR made materially false and misleading statements regarding its business operations and the Global Household Goods Contract, which led to investor damages when the truth was revealed [5]. Group 2: Rosen Law Firm's Credentials - Rosen Law Firm emphasizes the importance of selecting qualified legal counsel with a proven track record in securities class actions, highlighting its own success in recovering hundreds of millions for investors [4]. - The firm achieved the largest securities class action settlement against a Chinese company at the time and has been consistently ranked among the top firms for securities class action settlements since 2013 [4].

Core Viewpoint - A class action securities lawsuit has been filed against Fortinet, Inc. for alleged securities fraud affecting investors between November 8, 2024, and August 6, 2025 [1][2]. Group 1: Lawsuit Details - The lawsuit claims that Fortinet's management made false statements regarding the refresh cycle of their products, asserting it would be more profitable than it actually was, as it involved old products that represented a "small percentage" of the Company's business [2]. - It is alleged that Fortinet misrepresented the number of FortiGate firewalls eligible for upgrades and that the refresh momentum was overstated, with approximately half of the refresh completed in just a few months by the end of Q2 2025 [2]. Group 2: Next Steps for Investors - Investors who suffered losses during the specified timeframe have until November 21, 2025, to request appointment as lead plaintiff, although participation in any recovery does not require serving in this role [3]. - Class members may be entitled to compensation without any out-of-pocket costs or fees, and there is no obligation to participate [3]. Group 3: Firm Background - Levi & Korsinsky, LLP has a history of securing hundreds of millions of dollars for shareholders and has been recognized as one of the top securities litigation firms in the United States for seven consecutive years [4].

Core Viewpoint - Rosen Law Firm is reminding investors who purchased Fluor Corporation securities between February 18, 2025, and July 31, 2025, about the upcoming lead plaintiff deadline on November 14, 2025, for a class action lawsuit [1][2] Group 1: Class Action Details - Investors who bought Fluor securities during the specified Class Period may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [1] - A class action lawsuit has already been filed, and interested parties must move the Court to serve as lead plaintiff by the deadline [2] - The Rosen Law Firm emphasizes the importance of selecting qualified counsel with a successful track record in securities class actions [3] Group 2: Case Allegations - The lawsuit alleges that Fluor Corporation made false and misleading statements regarding project costs and financial guidance, particularly related to the Gordie Howe International Bridge and Texas highway projects [4] - It is claimed that costs were increasing due to subcontractor design errors, price hikes, and scheduling delays, which negatively impacted Fluor's business and financial results [4] - The lawsuit asserts that Fluor's financial guidance for 2025 was unreliable, and the effectiveness of its risk mitigation strategies was overstated [4]

Core Viewpoint - Rosen Law Firm is reminding purchasers of WPP plc American Depositary Shares (ADS) about a class action lawsuit and the upcoming lead plaintiff deadline of December 8, 2025 [1][3]. Group 1: Class Action Details - Investors who purchased WPP ADSs between February 27, 2025, and July 8, 2025, may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [2]. - A class action lawsuit has already been filed, and interested parties can join by submitting a form or contacting the law firm [3][6]. - The lawsuit claims that WPP provided misleading statements about its media arm's capabilities, leading to investor damages when the true situation was revealed [5]. Group 2: Law Firm Credentials - Rosen Law Firm emphasizes the importance of selecting qualified counsel with a successful track record in securities class actions, highlighting its own achievements in this area [4]. - The firm has secured significant settlements for investors, including over $438 million in 2019, and has been consistently ranked among the top firms for securities class action settlements [4].

Core Viewpoint - Faruqi & Faruqi, LLP is investigating potential claims against WPP plc due to allegations of false and misleading statements regarding the company's expected revenue for fiscal year 2025, leading to significant investor losses [3][5]. Group 1: Allegations and Company Performance - The complaint alleges that WPP and its executives violated federal securities laws by making false statements and failing to disclose material information about the company's media division performance [5]. - WPP's executives expressed confidence in revitalizing the media division and claimed that new business wins would offset losses, while concealing the true challenges faced by the company [5]. - On July 9, 2025, WPP reported a deterioration in performance for Q2 2025, attributing it to macroeconomic uncertainties and weaker new business than expected [6]. Group 2: Stock Price Impact - Following WPP's trading update on July 9, 2025, the company's stock price fell from $35.82 per share to $29.34 per share, marking an approximate decline of 18.1% in one day [7]. Group 3: Legal Proceedings - Investors who purchased WPP securities between February 27, 2025, and July 8, 2025, are encouraged to contact Faruqi & Faruqi to discuss their legal rights, with a deadline of December 8, 2025, to seek lead plaintiff status in the class action [3][9].

Core Viewpoint - Faruqi & Faruqi, LLP is investigating potential claims against KBR, Inc. related to alleged violations of federal securities laws, with a deadline for investors to seek lead plaintiff status in a class action lawsuit by November 18, 2025 [4][6]. Group 1: Allegations Against KBR - The complaint alleges that KBR and its executives made false and misleading statements regarding the HomeSafe's ability to fulfill the Global Household Goods Contract, despite knowing about the U.S. Department of Defense's concerns [6]. - The lawsuit claims that KBR's statements about its business operations and prospects were materially false and misleading, leading to investor damages when the truth was revealed [6]. Group 2: Stock Price Impact - Following the announcement of the termination of the Global Household Goods Contract, KBR's stock price fell by $3.85 per share, or 7.29%, closing at $48.93 on June 20, 2025 [7]. - On the next trading day, KBR's stock experienced an additional decline of $1.30, or 2.65%, closing at $47.63 on June 23, 2025 [7]. Group 3: Legal Process and Participation - The lead plaintiff in the class action will be the investor with the largest financial interest who is adequate and typical of class members, overseeing the litigation on behalf of the class [8]. - Any member of the class can move to serve as lead plaintiff or choose to remain an absent class member without affecting their ability to share in any recovery [8].

Core Viewpoint - MoonLake Immunotherapeutics faced a significant decline in share price following the announcement of disappointing Phase 3 trial results for its product candidate sonelokimab (SLK), leading to a securities class action lawsuit alleging misleading statements about the drug's efficacy and trial design [1][2][6]. Company Overview - MoonLake Immunotherapeutics is a clinical-stage biotechnology company focused on treating skin inflammatory diseases, specifically targeting cytokines IL-17A and IL-17F [3][4]. Trial Results and Market Reaction - The Phase 3 trial results revealed that only one of the two trials achieved statistical significance, with the efficacy of SLK being substantially lower than that of the competitor's FDA-approved product, BIMZELX [6]. - Following the announcement on September 28, 2025, MoonLake's share price plummeted by $55.75, approximately 90%, on September 29, 2025 [2][6]. Allegations of Misleading Statements - The lawsuit claims that MoonLake made false and misleading statements regarding SLK's advantages over BIMZELX, including assertions about superior efficacy and the unique benefits of its Nanobody structure [5][6]. - Specific allegations include misleading information about the clinical benefits of SLK compared to traditional monoclonal antibodies and the expected clinical efficacy based on its structural advantages [5]. Legal Proceedings - A securities class action has been filed against MoonLake, with a focus on the company's statements about SLK's trial design and efficacy data [1][3]. - The lead plaintiff deadline for the class action is set for December 15, 2025, and the firm Hagens Berman is actively seeking investors who suffered losses to participate in the lawsuit [3][6].

Core Viewpoint - A class-action lawsuit has been filed against KBR, Inc. alleging misleading statements made by the company prior to the cancellation of a significant military contract, which adversely affected its business outlook [1][2]. Group 1: Lawsuit Details - The lawsuit targets KBR investors who acquired securities between May 6, 2025, and June 19, 2025, and seeks to represent those who suffered substantial losses [2]. - The legal action claims that KBR executives provided an overly optimistic outlook on a crucial partnership just before its collapse [2]. Group 2: Contract Cancellation Impact - The lawsuit arises from the U.S. Department of Defense's cancellation of its global household goods contract with HomeSafe Alliance LLC, a joint venture led by KBR, announced on June 20, 2025 [3]. - Following the contract termination, KBR shares dropped over 7% due to the loss of a contract valued at up to $20 billion over a potential nine-year term [3]. Group 3: Misrepresentation Allegations - On May 6, 2025, during its Q1 earnings call, KBR assured investors that the HomeSafe partnership was "strong" and projected a mid-point revenue contribution of about $400 million for 2025 [4]. - Just weeks later, on June 19, 2025, HomeSafe disclosed the termination of the contract for cause, attributed to operational issues, which KBR allegedly knew about but did not disclose to investors [5]. Group 4: Financial Revisions - After the contract termination, KBR revised its low-end 2025 revenue guidance downward by approximately $900 million (-9%) during its Q2 2025 financial results announcement on July 31, 2025 [6]. - KBR management acknowledged operational challenges during the earnings call, raising questions about whether the company intentionally misled investors regarding the contract's status [6].

Core Viewpoint - Rosen Law Firm is reminding investors who purchased common stock of Tronox Holdings plc between February 12, 2025, and July 30, 2025, about the upcoming lead plaintiff deadline on November 3, 2025, for a class action lawsuit [1][2]. Group 1: Class Action Details - Investors who bought Tronox common stock during the specified Class Period may be eligible for compensation without any out-of-pocket fees through a contingency fee arrangement [1]. - A class action lawsuit has already been filed, and interested parties must move the Court to serve as lead plaintiff by the November 3, 2025 deadline [2][6]. Group 2: Law Firm Credentials - Rosen Law Firm emphasizes the importance of selecting qualified legal counsel with a successful track record in securities class actions, highlighting its own achievements, including the largest securities class action settlement against a Chinese company at the time [3]. - The firm has consistently ranked among the top in securities class action settlements, recovering hundreds of millions of dollars for investors, including over $438 million in 2019 alone [3]. Group 3: Case Allegations - The lawsuit alleges that Tronox's management made overly positive statements regarding the company's growth and strength in its pigment and zircon commercial division while concealing material adverse facts about its forecasting capabilities [4]. - Despite optimistic long-term projections, Tronox's sales continued to decline, and costs increased, leading to a failure in meeting revenue projections, which resulted in investor damages when the true situation was revealed [4].

Core Viewpoint - Faruqi & Faruqi, LLP is investigating potential claims against WPP plc due to allegations of false and misleading statements regarding the company's expected revenue for fiscal year 2025, leading to significant investor losses [3][5]. Group 1: Allegations Against WPP - The complaint alleges that WPP and its executives violated federal securities laws by making false statements and failing to disclose material information about the company's media division performance [5]. - WPP's executives expressed confidence in revitalizing the media division and claimed that new business wins would offset losses, while concealing the true challenges faced by the company [5]. - The company was reportedly losing significant market share to competitors, which was not disclosed to investors, leading to purchases of WPP securities at inflated prices [5]. Group 2: Impact on Stock Price - On July 9, 2025, WPP announced a deterioration in performance, attributing it to macroeconomic uncertainties and weaker new business than expected, which led to a dramatic stock price decline [6][7]. - The stock price fell from $35.82 per share on July 8, 2025, to $29.34 per share on July 9, 2025, marking an approximate decline of 18.1% in one day [7]. Group 3: Legal Proceedings - Investors who suffered losses are encouraged to contact Faruqi & Faruqi to discuss their legal rights, with a deadline of December 8, 2025, to seek the role of lead plaintiff in the class action [3][9]. - The lead plaintiff is defined as the investor with the largest financial interest in the relief sought, who will oversee the litigation on behalf of the class [8].